S-EPMC10844082 - Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment. - OmicsDI

Unknown

Dataset Information

Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment.

ABSTRACT:

SUBMITTER: Hanel G

PROVIDER: S-EPMC10844082 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature